Horizon Therapeutics

E129: Sam Altman plays chess with regulators, AI's "nuclear" potential, big pharma bundling & more

All-In Podcast

Company Amgen is attempting to acquire; discussed regarding its portfolio of orphan drugs and the FTC's lawsuit.